Your browser doesn't support javascript.
loading
Evaluation of dosing strategy for pembrolizumab for oncology indications.
Freshwater, Tomoko; Kondic, Anna; Ahamadi, Malidi; Li, Claire H; de Greef, Rik; de Alwis, Dinesh; Stone, Julie A.
Affiliation
  • Freshwater T; Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ USA.
  • Kondic A; Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ USA.
  • Ahamadi M; Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ USA.
  • Li CH; Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ USA.
  • de Greef R; Quantitative Solutions, a Certara Company, Kloosterstraat 9, Oss, The Netherlands.
  • de Alwis D; Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ USA.
  • Stone JA; Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ USA.
J Immunother Cancer ; 5: 43, 2017.
Article in En | MEDLINE | ID: mdl-28515943
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Neoplasms Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: J Immunother Cancer Year: 2017 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Neoplasms Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: J Immunother Cancer Year: 2017 Document type: Article Country of publication: